Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin
Purpose: Oxidative stress-induced mitochondrial damage is the main event in acquired brain injuries (ABI). This study aimed to evaluate the effects of melatonin, a mitochondria-targeted antioxidant, on mitochondrial and brain injury markers, and the clinical outcomes of patients with ABI. Methods: I...
Saved in:
Main Authors: | Bahareh Hakiminia (Author), Babak Alikiaie (Author), Fariborz Khorvash (Author), Sarah Mousavi (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Licorice as Adjunctive Therapy in Critically Ill Patients with COVID-19: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
by: Babak Alikiaie, et al.
Published: (2024) -
Neurobehavioral Changes after Acquired Brain Injury
Published: (2020) -
Melatonin as a Therapy for Preterm Brain Injury: What Is the Evidence?
by: Silke Häusler, et al.
Published: (2023) -
Clinical significance of detecting serum melatonin and SBDPs in brain injury in preterm infants
by: Caixia Yan, et al.
Published: (2019) -
Melatonin suppresses the brain injury after cerebral ischemia/reperfusion in hyperglycaemic rats
by: Dalia O Saleh, et al.
Published: (2020)